People: K-V Pharmaceutical Company (KVa)

KVa on New York Consolidated

3.03USD
9 Feb 2010
Price Change (% chg)

$-0.16 (-5.02%)
Prev Close
$3.03
Open
--
Day's High
$3.19
Day's Low
$2.89
Volume
524,839
Avg. Vol
292,465
52-wk High
$5.36
52-wk Low
$0.55

view people for:

Summary

Name Age Since Current Position
Hatfield, Terry 62 2008 Chairman of the Board
Van Vliet, David 54 2008 Interim President, Interim Chief Executive Officer
McHugh, Thomas 44 2009 Interim Chief Financial Officer, Vice President - Finance, Interim Treasurer, Corporate Controller
McCullough, Patricia 56 2006 Chief Executive Officer of ETHEX Corporation
Bleser, Rita 52 2007 President - Pharmaceutical Manufacturing Division
Divis, Gregory 42 2007 President, Ther-Rx Corporation
Anderson, Michael 60 2008 CEO - ETHEX Corporation, Corporate Vice President - Industry Presence and Development
Chiostri, Raymond 74 2006 Corporate Vice President
Brady, Paul 46 2007 Corporate Vice President - Business Development Administration
Chibnall, Richard 53 2005 Vice President - Finance, Chief Accounting Officer
Hermelin, Marc 67 2008 Director
Schellenger, Norman 78 1998 Director
Carlie, Kevin 54 2001 Director
Bellin, Jean 59 2003 Director
Hermelin, David 43 2008 Director
Killmer, Jonathon 68 2006 Director
» Insider Trading

Biographies

Name Description
Hatfield, Terry Mr. Terry B. Hatfield is Chairman of the Board of K-V Pharmaceutical Company. He is President of ZeaVision, a nutraceutical company with a focus on eye health, since 2003; Consultant for merger and acquisition transactions from 2001 to 2003.
Van Vliet, David Mr. David A. Van Vliet is Interim President, Interim Chief Executive Officer of K-V Pharmaceutical Company since December 2008. He has been President and Chief Executive Officer, ETHEX Corporation from August 2008 to December 2008; Chief Administration Officer of the Company from September 2006 to August 2008; member of the Board of Directors of the Company from August 2004 to September 2006; President and Chief Operating Officer of Angelica Corporation from June 2005 to September 2006; President and Chief Executive Officer of Growing Family, Inc. from 1998 to June 2005.
McHugh, Thomas Mr. Thomas S. McHugh is Interim Chief Financial Officer, Vice President - Finance, Interim Treasurer, Corporate Controller of K-V Pharmaceutical Company since September 2009; Vice President of Finance and Corporate Controller from January 2009 to September 2009; Managing Director and Global Controller, BearingPoint, Inc. from December 2005 to November 2008; Chief Financial Officer, Huttig Building Products, Inc., from 2000 to 2005.
McCullough, Patricia Mr. McCullough is Chief Executive Officer, ETHEX Corporation of K-V Pharmaceutical Company since January 2006; Group Vice President, Business Development and Strategic Planning, Taro Pharmaceuticals from September 2003 to January 2006; Senior Vice President, Account Development, Cardinal Health from June 2000 to July 2003.
Bleser, Rita Rita E. Bleser is President, Pharmaceutical Manufacturing Division of K-V Pharmaceutical Company since April 2007; Vice President Technology, Tyco Healthcare from September 2001 to April 2007.
Divis, Gregory Mr. Gregory J. Divis, Jr., is President, Ther-Rx Corporation of K-V Pharmaceutical Company since July 2007; Vice President, Business Development and Life Cycle Management, Sanofi-Aventis U.S. from February 2006 to July 2007; Vice President Sales, Respiratory East, Sanofi-Aventis U.S. from June 2004 to February 2006; Executive Director, Sales and Marketing National Accounts, Reliant Pharmaceuticals from December 2003 to June 2004; Vice President and Country Manager United Kingdom and Ireland, Schering-Plough from May 2002 to December 2003; Vice President, Field Operations Oncology-Biotech Division, Schering- Plough from October 2000 to April 2002.
Anderson, Michael Mr. Michael S. Anderson is Chief Executive Officer - ETHEX Corporation, Corporate Vice President - Industry Presence and Development of K-V Pharmaceutical Company. He has been Chief Executive Officer, ETHEX Corporation since December 2008; Corporate Vice President, Industry Presence and Development since February 2006; Chief Executive Officer, Ther-Rx Corporation from February 2000 to February 2006.
Chiostri, Raymond Raymond F. Chiostri is a Corporate Vice President, KV Pharmaceutical Company since September 2006; Chairman and Chief Executive Officer of Particle Dynamics, Inc. from 1999 to September 2006.
Brady, Paul Mr. Paul T. Brady is Corporate Vice President - Business Development Administration of K-V Pharmaceutical Company since 2007; President, Particle Dynamics, Inc. since 2003; Senior Vice President and General Manager, International Specialty Products Corporation from June 2002 to January 2003; Senior Vice President, Commercial Director, North and South America International Specialty Products from 2000 to 2002.
Chibnall, Richard Mr. Richard H. Chibnall is Vice President - Finance, Chief Accounting Officer of K-V Pharmaceutical Company since June 2005. He served as Vice President, Finance from February 2000 to June 2005.
Hermelin, Marc Mr. Marc S. Hermelin is Director of KV Pharmaceutical Company. He was Chairman of the Board of Directors from August 2006 to December 2008; Chief Executive of the Company from 1974 to December 2008; Vice Chairman of the Company from 1974 to August 2006.
Schellenger, Norman Mr. Norman D. Schellenger is Director of K-V Pharmaceutical Company since 1998. He has been a Director of ProEthics Pharmaceuticals, Inc. since 2004. He retired from UCB Pharma in 1996 where he served as Vice President Sales and Marketing from 1995 to 1996. Prior to that he was President of Whitby Pharmaceuticals from 1992 to 1994.
Carlie, Kevin Mr. Kevin S. Carlie is Director of K-V Pharmaceutical Company since 2001.He is member or Partner since 1984 in the Certified Public Accounting Firm of Stone Carlie & Company, LLC, and its predecessors.
Bellin, Jean Mr. Jean M. Bellin is Director of K-V Pharmaceutical Company since 2003. He is President of Metagenics, Inc., a life sciences company that develops, manufactures and markets science-based medical foods and nutraceuticals, since September 2006; CEO of Mountain View Pharmaceuticals, Inc., a biopharmaceutical company focused on the development of long-acting therapeutic proteins, from 2004 to 2005; Vice President of Osteohealth Company and Luitpold Animal Health from 2003 to 2004; CEO and Director of New Medical Concepts from 1997 to 2001.
Hermelin, David Mr. David S. Hermelin is a Director of K-V Pharmaceutical Company since 2004. He has been Vice President of Corporate Strategy and Operations Analysis of the Company from 2002 to December 2008; Vice President of Corporate Planning and Administration of the Company from 1995 to 2002; Manager of Strategic Planning and Administration of the Company from 1993 to 1995; Manager of Business Development of the Company from 1990 to 1993.
Killmer, Jonathon Mr. Jonathon E. Killmer is Director of K-V Pharmaceutical Company. He has been Chairman of Blue Plus, a Minnesota domiciled HMO, since 2006; retired in 2004 as Chief Operating Officer from Hypercom Corporation, an electronic payment products and services company; Consultant of Hypercom Corporation from 2002 to 2004.

Insider Trading

Name Shares Traded Price
FORSYTH JANICE C 40,000 $0.00
HERMELIN MARC S 18,631 $0.00
HERMELIN MARC S 2,234,145 $0.00
HERMELIN MARC S 45,671 $0.00
CHIBNALL RICHARD H 28,000 $5.00
HERMELIN MARC S 233,663 $0.00
HERMELIN MARC S 46,800 $0.00
HERMELIN MARC S 186,863 $0.00
HERMELIN MARC S 46,800 $0.00
HERMELIN MARC S 186,863 $0.00
HERMELIN MARC S 23,500 $0.00
HERMELIN MARC S 70 $0.00
HERMELIN MARC S 70 $0.00
HERMELIN MARC S 23,500 $0.00
HERMELIN MARC S 23,500 $0.00
HERMELIN MARC S 30,500 $0.00
HERMELIN MARC S 30,500 $0.00
HERMELIN MARC S 70,500 $0.00
HERMELIN MARC S 70,500 $0.00
HERMELIN MARC S 23,500 $0.00
DIVIS GREG J 1,225 $28.60
HERMELIN MARC S 133,333 $0.00
HERMELIN MARC S 133,333 $0.00
HERMELIN MARC S 133,334 $0.00
HERMELIN MARC S 400,000 $0.00
» Full list on Insider Trading
view people for: